Non-Small-Cell Lung Cancer-Sensitive Detection of the p.Thr790Met EGFR Alteration by Preamplification before PNA-Mediated PCR Clamping and Pyrosequencing

Targeted therapies and, more precisely, EGFR tyrosine kinase inhibitors (TKIs) have been a major improvement in the therapeutic management of EGFR-mutated non-small-cell lung cancers (NSCLCs). Earlier administration of these TKIs throughout tumor progression is imperative to improve patient outcomes...

Descripción completa

Detalles Bibliográficos
Autores principales: Billaud, Amandine, Verriele, Veronique, Dauvé, Jonathan, Chevalier, Louise-Marie, Morel, Alain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7460542/
https://www.ncbi.nlm.nih.gov/pubmed/32751202
http://dx.doi.org/10.3390/diagnostics10080527

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7460542/
https://www.ncbi.nlm.nih.gov/pubmed/32751202
http://dx.doi.org/10.3390/diagnostics10080527

Ejemplares similares